3 results
Approved WMOPending
The primary hypothesis of the study is that the use of icodextrin leads to a reduction in extracellular volume compared to glucose 2.27%, but that the effects of icodextrin and glucose 2.27% on plasma will not differ.
Approved WMORecruiting
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD ascompared with placebo in patients with mild AD dementia.
Approved WMORecruiting
The aim of the study is to gain more insight into the working factors of the Feelee app as a supportive tool to TAU in forensic outpatient settings. We examine whether the daily tracking of emotions by means of emojis together with the collected…